These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? Shibata T; Ogawa N; Koyama I; Ksaneko N; Hokazono K; Omoto R Transplant Proc; 1993 Feb; 25(1 Pt 2):1145-8. PubMed ID: 7680147 [No Abstract] [Full Text] [Related]
5. [Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation]. Bosimini E Ital Heart J Suppl; 2000 Nov; 1(11):1494-5. PubMed ID: 11109204 [No Abstract] [Full Text] [Related]
7. Additive effects of hyperlipidemia and rejection on development of graft coronary vasculopathy following cardiac transplantation. El-Hamamsy I; Perrault LP Can J Cardiol; 2005 Mar; 21(4):373; author reply 373-4. PubMed ID: 15838569 [No Abstract] [Full Text] [Related]
8. [Cytomegalovirus arteriolitis: gangrene of the feet and early coronary disease after heart transplantation]. Loire R; Bastien O; Tabib A; Vigneron M Arch Mal Coeur Vaiss; 1993 Feb; 86(2):255-8. PubMed ID: 8395793 [TBL] [Abstract][Full Text] [Related]
9. Coronary angioscopy in the diagnosis of graft coronary artery disease in heart transplant recipients. Ventura HO; White CJ; Ramee SR; Collins TJ; Mesa JE; Jain A J Heart Lung Transplant; 1991; 10(3):488. PubMed ID: 1854778 [No Abstract] [Full Text] [Related]
10. Early risk factors for transplant coronary artery disease and cardiac allograft failure. Labarrere CA Ital Heart J; 2001 Sep; 2 Suppl 3():26S-28S. PubMed ID: 11593926 [No Abstract] [Full Text] [Related]
11. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. Baan CC; Holweg CT; Niesters HG; van Gelder T; Mol WM; Zondervan PE; Mochtar B; Balk AH; Weimar W J Heart Lung Transplant; 1998 Apr; 17(4):363-73. PubMed ID: 9588581 [TBL] [Abstract][Full Text] [Related]
12. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]
13. Graft coronary disease: the lesions and the patients. Billingham ME Transplant Proc; 1989 Aug; 21(4):3665-6. PubMed ID: 2669276 [No Abstract] [Full Text] [Related]
14. [Heart transplantation: hemodynamic follow-up at yearly intervals]. Razzolini R; Stritoni P; Boffa GM; Viena P; Isabella G; Ramondo A; Chioin R G Ital Cardiol; 1989 Dec; 19(12):1171-4. PubMed ID: 2634575 [No Abstract] [Full Text] [Related]
15. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation. Bouchard D; Despatis MA; Buluran J; Cartier R Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698 [TBL] [Abstract][Full Text] [Related]
16. Association between acute rejection and cardiac allograft vasculopathy. Dandel M; Hummel M; Wellnhofer E; Kapell S; Lehmkuhl HB; Hetzer R J Heart Lung Transplant; 2003 Sep; 22(9):1064-5. PubMed ID: 12957619 [No Abstract] [Full Text] [Related]
17. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation. Kocík M; Málek I; Janek B; Zelízko M; Pirk J Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382 [TBL] [Abstract][Full Text] [Related]
18. The scourge and enigmatic journey of cardiac allograft vasculopathy. Mehra MR J Heart Lung Transplant; 2017 Dec; 36(12):1291-1293. PubMed ID: 29173389 [No Abstract] [Full Text] [Related]